News & Media

Letter From the Editor

Written by: Scott Finger | sfinger@ciscrp.org Dear readers, If you have been following CISCRP and our newsletter, you know about some of the exciting and innovative changes we have made

Medical Hero Spotlight: Phyllis Kaplan & Type 1 Diabetes

Written by: Melissa Daley | mdaley@ciscrp.org Phyllis has a vague recollection of waking up in a hospital with tubes attached to her body, and a distinct memory of saying, “Take

Why Clinical Trial Diversity Is Key To Increasing Access To Routine Care And Innovative Treatment Options

By: Luther T. Clark, MD, Deputy Chief Patient Officer, Merck The COVID-19 pandemic has shone a light on longstanding health care disparities and amplified the importance of clinical trial diversity,

Results From The 2021 CISCRP Perceptions & Insights Study Coming Soon

By: Jessica Cronin | jcronin@ciscrp.org CISCRP is excited to announce that the full results of the 2021 global Perceptions & Insights Study will be available this fall! This latest study

PLSP: The Results Of The DESTINY-Breast Cancer01 Clinical Trial Published In Future Oncology

Written by: Joan Chambers | jchambers@ciscrp.org CISCRP and Oxford PharmaGenesis collaborated with Daiichi Sankyo, AstraZeneca, and Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center in New York to

AWARE for All Fall Updates

Written by: Hope Ventricelli | hventricelli@ciscrp.org At the beginning of 2020, the CISCRP Events team had their work cut out. We had to adapt our live educational event (AWARE for

Media Awareness

CISCRP implements media campaigns throughout the year to build clinical trial awareness in patient communities and the general public. To learn more visit our Media Awareness webpage.



VIEW OUR LATEST CAMPAIGN